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1. Introduction 
Amyloidosis comprises a group of chronic disease characterized by the deposition in 
different organs of an insoluble and fibrilar protein known as amyloid. AA-amyloidosis is 
commonly found in mammalian, including mice, and has been associated with 
inflammatory chronic diseases, such as leprosy, tuberculosis and rheumatoid arthritis, due 
to persistent high plasma concentration of SAA, a conserved protein. Leishmanasis are 
chronic diseases; however, the amyloidosis associated to them is rarely reported in the 
human being. Nevertheless, the association of leishmaniasis and amyloidosis has been 
described in the animal model during the course of infection. Mice experimentally infected 
by Leishmania amanozensis may present, after six months of infection, amyloid deposition in 
the liver, the spleen and less frequently in the ovaries. Macroscopically, these organs 
presented a whitish yellow-coloration diffusely distributed in the organ parenchyma. 
Histologicaly, the amyloid deposition is observed mainly among hepatocytes, in marginal 
zone of the spleen or in the renal glomerular tufts. 
Proteins are found in all cells and carry out a variety of important cellular functions. Folding 
and unfolding are crucial ways of regulating biological activity and targeting proteins to 
different cellular locations. Failure to fold correctly, or to remain correctly folded, will 
therefore give rise to the malfunctioning of living systems and hence to disease (Dobson, 
2003). 
The largest group of misfolding diseases, which include numerous neurodegenerative 
disorders and the amyloidosis, originates from the conversion of specific proteins from their 
soluble functional states into stable, highly ordered, filamentous protein aggregates, known 
as amyloid fibrils (Uversky, 2003) 
In accordance to Xue et al. (2010), the time course of amyloidogenesis and the cellular 
responses to the presence of amyloid fibrils depends on the extent of fibril fragmentation 
and that length, width and surface area of amyloid fibrils may play important roles in the 
mechanism of amyloid deposition. 
The term amyloid was coined by the pathologist Virchow, in 1854, to describe an 
extracellular material found in the liver during the necroscopic exam. This term was used 
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because when this affected organ was treated with an iodine-sulfuric acid test, it turned 
blue, a positive test for starch . 
It has been described 27 amyloid protein in human being and at least 9 in animal (Sipe et al., 
2010). This protein in histological sections stained by hematoxylin has an amorphous 
hyaline appearance and when it stained by red Congo and viewed by conventional 
polarized light the amyloid protein present a green birefringence. The amyloid is not a 
unique protein presented in tissue deposition it comprises substance such as 
glicosaminoglycans, substance P and amyloid protein.  
Based on the distribution of the amyloid, amyloidosis is classified in systemic and localized. 
The systemic amyloidosis are classified in four types: AA amyloidosis, AL amyloidosis, B2 
microglobulin and ATR amyloidosis.  
AA amyloidosis, in both animals and human, is associated with long–standing chronic 
infections or inflammatory reaction. In animals is more frequent in  bovine suffering from 
mastitis, traumatic reticuloperintonitis, metritis and pododermatitis (Elitok et al., 2008). 
This type of amyloidosis is characterized by high concentration in the blood stream of 
SAA.   
SAA is an acute phase protein serum amyloid A produced mainly hepatocytes, has a 
molecular weight of approximately 12–14 kD and plays a role in reparation of tissue 
damaged by the inflammatory response. Can be proteolytically processed into an N-
terminal cleavage product of approximately 44 to 100 residues that is deposited as amyloid 
in vital organs, which under normal conditions, all of the SAA is completely degraded. The 
deposition of this substance lead to cellular dysfunction and the clinical signs depend on the 
affected organs (Elimova et al., 2009; Sandri et al., 2008). 
2. Amyloidosis x Leishmaniasis 
Leishmaniasis are infectious and parasitic diseases that affect animals and human beings, 
caused by protozoan parasites of the Leishmania species. The genus Leishmania comprises 
protozoa parasites with a digenetic life cycle, living alternately in vertebrates hosts and 
phebotomine sandflies. The insect is responsible for transmission of parasites of a 
mammalian to another (Asfhord, 2000). In vertebrate hosts, Leishmania survives as 
amastigotes form, primarily in macrophages, that are ingested when the female sandfly 
takes a blood meal from an infected host. Several clinical syndromes are subsumed under 
the term leishmaniasis: most notably visceral, cutaneous, and mucosal leishmaniasis, 
which result from replication of the parasite in macrophages in the mononuclear 
phagocyte system, dermis, and naso-oropharyngeal mucosa, respectively (Herwaldt, 
1999). 
AA amyloidosis is rarely described in naturally infection by Leishmania spp. However 
several author have been reported the occurrence of this disease in experimental infection 
(Carvalho et al., 2008; Barbosa-Santos et al., 1984).  
Even in murine model it has been observed that AA amyloidosis occur only in some 
strains of mice. In different experiment where DBA/2, Swiss, BALB/c, C57BL/6 female 
were infected with promastigote and amastigote of L. amanozensis just Swiss and 
C57BL/6 presented amyloidosis in the course of the infection (Cupolillo et al., 1998 
Carvalho et al., 2008). Several hypotheses have been postulated to explain why a minority 
of patients displayed AA amyloidosis during chronic inflammatory infection. In 
accordance to Westermark and Westermark al., 2009, the individuals probably have 
www.intechopen.com
 Amyloidosis Associated to Leishmania Infection in Murine Model 
 
193 
deficient degradation system for aggregated proteins or they had received one or several 
nucleation or seeding factors. Even C57BL/6 mice, an inbred strain, challenged with that 
same inoculum some animals did not display AA amyloidosis after the long term after the 
infection. Studies show that Swiss male mice were more prone to AA amyloid deposition 
than female. This may be one of explanation why not all C57BL/6 mice displayed 
amyloidosis. On the other hands, BALB/c mice did not present amyloid deposition 
probably due to high susceptibility to L. amazonensis, what lead to generalized disease at 
60 or 90 days post infection. Thus, several factors such as sex, duration and type of 
infection and polymorphism can contribute to onset of AA amyloidosis (Shtrasburg et al., 
2004; van der Hilst, 2011). 
The pathogenesis of leishmaniasis is related to the genetic background of the host and the 
Leishmania species and the modulation of T-cell immune response can be influenced by the 
infective Leishmania species as described by Silveira et al. (2009), since the clinical 
manifestation of cutaneous depends on both the host immune response and the specie of 
Leishmania involved. 
All mice that presented amyloid deposition develop palpable lesion in skin in the delayed 
phase of the infection, which allowed that this animals were maintained for long period 
after infection. When mice presented primary lesion they were euthanatized. The necropsy 
exam revealed that liver, spleen and kidney presented pale and enlargement. The other 
organs did not present macroscopic lesions. 
The histological sections   stained by haematoxylin and eosin showed the liver presented an 
inflammatory reaction in portal area and deposition of a hyaline and amorphous substance 
among the hepatocytes. The same substance was seen in renal corpuscle and in the splenic 
marginal zone. In additional, C57BL/6 mouse showed a diffuse amyloid deposition in the 
ovary. The Congo red staining revealed that the amorphous substance presented in the 
sampled organs had a yellow-green birefringence under polarized light, confirming the 
occurrence of amyloid protein deposition. This dye presents a linear molecule that permits 
that hydrogen bonding of its azo and amino radicals to hydroxyls radicals of amyloid 
protein, which explain the birefringence under polarized light. 
Amyloid A fibril protein in secondary amyloidosis is designated as AA protein, which is 
derived from the precursor protein known as serum amyloid A, or SAA. SAA protein is an 
acute-phase reactant produced by liver cells in response to macrophage-derived 
inflammatory cytokines such as interleukin 1, interleukin 6 and tumor necrosis factor-alpha. 
A major factor responsible for the development of AA amyloidosis is the increased synthesis 
and subsequent degradation of the precursor protein SAA1 under chronic inflammatory 
conditions (Ray et al., 2006). Approximately 45% of systemic amyloidosis reported in the 
literature is AA amyloidosis.  
Amyloidosis has been described in spleen and liver of dogs naturally infected with L.  
infantum (Bely and Apathy, 2000; Poli et al., 1991; George et al., 1976). In hamsters, this 
pathology has been reported in adrenal gland (Novoa et al., 1990) in mice amyloidosis is 
most common in liver (Figure 1), spleen and kidney (Figure 2) Here, inflammatory infiltrates 
were observed in both medullary and cortical regions, however amyloidosis depositions 
were not demonstrated, suggesting passage of parasitic antigen though these organs but 
without evidence of parasites. Previous studies showed that Swiss mice infected with L.  
amazonensis amastigotes had developed amyloidosis in spleen, liver , and kidney  10 months 
post-infection (Barbosa-Santos et al., 1984).   
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Fig. 1. Liver – Amyloidal deposits among hepatocytes cells (arrows) – Gomori Trichrome 
Stain. Scale bar 100 µm.  
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Fig. 2. Kidney – Amyloidal deposits in the glomerular tuft (arrows) – Hematoxylin-Eosin. 
Scale bar 100 µm  
2.1 Conclusions remarks 
In murine model, the persistence of the Leishmania infection lead to  amyloid deposition, 
which may impair the function  of several organs, including, liver, spleen, kidney and ovary. 
The tecidual damage is caused by several factor. 
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